Fingerprint
Dive into the research topics of 'Chronic lymphocytic leukemia cells from ibrutinib treated patients are sensitive to Axl receptor tyrosine kinase inhibitor therapy'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Chronic lymphocytic leukemia cells from ibrutinib treated patients are sensitive to Axl receptor tyrosine kinase inhibitor therapy
Sutapa Sinha, Justin C. Boysen, Kari G. Chaffee, Brian F. Kabat, Susan L. Slager, Sameer A. Parikh, Charla R. Secreto, Tim Call, Tait D. Shanafelt, Jose F. Leis, Steven L. Warner, David J. Bearss, Asish K. Ghosh, Neil E. Kay
Research output: Contribution to journal › Article › peer-review
6
Scopus
citations